| Emily A Lansden, MA, CCC-SLP | |
|
494 W Central Ave, Delaware, OH 43015-1470 | |
| (740) 369-3650 | |
| (740) 369-0812 |
| Full Name | Emily A Lansden |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 494 W Central Ave, Delaware, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073763348 | NPI | - | NPPES |
| 2095245 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP8373 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily A Lansden, MA, CCC-SLP 494 W Central Ave, Delaware, OH 43015-1470 Ph: (740) 369-3650 | Emily A Lansden, MA, CCC-SLP 494 W Central Ave, Delaware, OH 43015-1470 Ph: (740) 369-3650 |
News Archive
Labopharm Inc. today announced it has initiated the regulatory approval process for its twice-daily tramadol-acetaminophen formulation in Europe under the Decentralized Procedure (DCP). The DCP provides an efficient mechanism that allows a company to simultaneously pursue regulatory approval for a medicinal product in multiple jurisdictions in Europe.
The applications for the EVT products – especially the EyeVision software – is many fold. Often seemingly complex tasks are solved with simple commands into EVTsoftware, for example the "Object Counter" in the inspection of production and packaging of condoms.
The meta analysis, which examined more than 4.5 million data points on more than 100 microarrays from mouse models, also identified more than 1,300 functional groups, including signaling and transcription pathways, which may also play an important role in establishing a capacity for a "high level of alcohol consumption."
A team from the National Institute for Infectious Diseases "L. Spallanzani" (INMI) has recently reported their study on 94 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections (47.9% symptomatic, 52.1% asymptomatic) that occurred after the first or second vaccine dose against SARS-CoV-2 in the Lazio region (Central Italy).
› Verified 4 days ago
Christina Anne Chambers, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 265 Lexington Blvd, Delaware, OH 43015 Phone: 614-323-3688 | |
Rhonda Granger, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 494 W Central Ave, Delaware, OH 43015 Phone: 740-369-3650 Fax: 740-369-0812 | |
Ondina Vega-behar, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2270 Warrensburg Rd, Delaware, OH 43015 Phone: 740-369-9614 | |
Alexandra Whaley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26 N Union St, Delaware, OH 43015 Phone: 740-362-9641 | |
Sarah Belcher, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 494 W Central Ave, Delaware, OH 43015 Phone: 740-369-3650 | |
Mrs. Tara Bergstedt, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 74 W William St, Delaware, OH 43015 Phone: 740-833-2384 |